RE: Base editing trial success11 Dec 2022 10:37
Crazy if that BBC article is correct, it is thought that up to a dozen patients could benefit.
As it says though very early days and tech can be used for other applications.
Imagine delivering an existing drug that is used extensively but is limited by it's toxicity. But delivering it in such a way that massively reduce the toxicity issue.